APA (7th ed.) Citation

Reitsam, N. G., Grozdanov, V. D., Löffler, C., Muti, H. S., Grosser, B., Kather, J. N., & Märkl, B. (2023). Novel biomarker SARIFA in colorectal cancer: Highly prognostic, not genetically driven and histologic indicator of a distinct tumor biology. Cancer gene therapy, 31(2), . https://doi.org/10.1038/s41417-023-00695-y

Chicago Style (17th ed.) Citation

Reitsam, Nic Gabriel, Veselin D. Grozdanov, Chiara Löffler, Hannah Sophie Muti, Bianca Grosser, Jakob Nikolas Kather, and Bruno Märkl. "Novel Biomarker SARIFA in Colorectal Cancer: Highly Prognostic, Not Genetically Driven and Histologic Indicator of a Distinct Tumor Biology." Cancer Gene Therapy 31, no. 2 (2023). https://doi.org/10.1038/s41417-023-00695-y.

MLA (9th ed.) Citation

Reitsam, Nic Gabriel, et al. "Novel Biomarker SARIFA in Colorectal Cancer: Highly Prognostic, Not Genetically Driven and Histologic Indicator of a Distinct Tumor Biology." Cancer Gene Therapy, vol. 31, no. 2, 2023, https://doi.org/10.1038/s41417-023-00695-y.